Intec Pharma Ltd. (NASDAQ: NTEC) WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Intec Pharma Ltd. (NASDAQ: NTEC) in connection with the proposed acquisition of the company by Decoy Biosystems, Inc. ("Decoy"). Upon consummation of the transaction, NTEC's shareholders will own approximately 25% of the combined entity, with Decoy shareholders owning approximately 75%. If you own NTEC shares and wish to discuss this investigation or your rights, please call us or visit our website: https://weisslawllp.com/ntec/ RumbleOn, Inc. (NASDAQ: RMBL) WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of